Previous studies have indicated that in adult smokers, a history of childhood pneumonia is associated with reduced lung function and chronic obstructive pulmonary disease. There have been few previous investigations using genome-wide association studies to investigate genetic predisposition to pneumonia. This study aims to identify the genetic variants associated with the development of pneumonia during childhood and over the course of the lifetime. Study subjects included current and former smokers with and without chronic obstructive pulmonary disease participating in the COPDGene Study. Pneumonia was defined by subject self-report, with childhood pneumonia categorized as having the first episode at ,16 years. Genome-wide association studies for childhood pneumonia (843 cases, 9,091 control subjects) and lifetime pneumonia (3,766 cases, 5,659 control subjects) were performed separately in non-Hispanic whites and African Americans. Non-Hispanic white and African American populations were combined in the meta-analysis. Top genetic variants from childhood pneumonia were assessed in network analysis. No single-nucleotide polymorphisms reached genome-wide significance, although we identified potential regions of interest. In the childhood pneumonia analysis, this included variants in NGR1 (P = 6.3 3 10 28 ), PAK6 (P = 3.3 3 10 27 ), and near MATN1 (P = 2.8 3 10 27 ). In the lifetime pneumonia analysis, this included variants in LOC339862 (P = 8.7 3 10 27 ), RAPGEF2 (P = 8.4 3 10 27 ), PHACTR1 (P = 6.1 3 10 27 ), near PRR27 (P = 4.3 3 10 27 ), and near MCPH1 (P = 2.7 3 10 27 ). Network analysis of the genes associated with childhood pneumonia included top networks related to development, blood vessel morphogenesis, muscle contraction, WNT signaling, DNA damage, apoptosis, inflammation, and immune response (P < 0.05). We have identified genes potentially associated with the risk of pneumonia. Further research will be required to confirm these associations and to determine biological mechanisms.
Clinical Trial Registration: NCT00608764Keywords: pneumonia; genome-wide association study; pediatrics; genetic epidemiology; chronic obstructive pulmonary disease
Clinical RelevanceTo the best of our knowledge, this study is the first to investigate the genetic factors that may be associated with pneumonia during childhood and across the lifetime. It may help identify children at risk of lung disease such as chronic obstructive pulmonary disease later in life. This could ultimately direct us toward a subtype of chronic obstructive pulmonary disease with early childhood origins and could help better prognosticate disease risk and treatment response. This work was supported by National Institutes of Health grants T32 HL007427 (E.K.S.), R01HL094635 (C.P.H.), R01NR013377 (C.P.H.), P01HL105339 (E.K.S.), R01HL089897 (J.D.C.), and R01HL089856 (E.K.S.). The COPDGene project is also supported by the COPD Foundation through contributions made to an Industry Advisory Board composed of AstraZeneca, Boehringer Ingelheim, Novartis,...